Bionano Genomics, Inc. (NASDAQ: BNGO), and Genoox, the healthcare technology company on a mission to make it easier for doctors, clinicians and researchers to run clinical genetic applications and act on genetic sequencing results, announced today the launch of the Genoox Integrated Platform for identification of structural variants.
October 18, 2018
· 3 min read